KAFAK-treated male mice had a nonsignificant trend toward increased latency scores compared to both the Sham group and the TBI group at days 5 and 7 ( Figure 4 C).
← all excerpts
Intranasal Delivery of Cell-Penetrating Therapeutic Peptide Enhances Brain Delivery, Reduces Inflammation, and Improves Neurologic Function in Moderate Traumatic Brain Injury.
1
—
—